PBYI
Puma Biotechnology, Inc.
9.80$
-0.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 61.6% | 67.8% | 66.8% | 67.2% | 71.0% | 69.2% | 67.5% | 70.1% | 70.8% | 75.2% | 73.8% | 75.3% | |
| 40.2% | 36.7% | 35.8% | 32.8% | 30.5% | 32.4% | 32.1% | 28.0% | 26.4% | 13.7% | 18.8% | 19.0% | |
| 41.8% | 41.6% | 50.0% | 47.2% | 43.8% | 47.3% | 47.5% | 49.3% | 46.5% | 45.1% | 52.7% | 48.7% | |
| 14.2% | 21.0% | 11.5% | 13.7% | 24.8% | 15.0% | 12.8% | 13.3% | 16.5% | 24.8% | 13.7% | 17.7% | |
| 2.8% | 3.1% | 3.3% | 4.4% | 1.2% | 4.1% | 4.5% | 4.4% | 4.7% | 2.5% | 4.5% | 6.9% | |
| 31.1% | 26.4% | 27.3% | 27.3% | 24.3% | 24.0% | 24.8% | 23.7% | 21.6% | 19.1% | 20.2% | 18.9% | |
| 81.0% | 76.8% | 76.2% | 76.3% | 67.8% | 56.8% | 50.5% | 46.3% | 43.2% | 39.7% | 33.4% | 28.1% | |
| 33.1% | 43.1% | 45.9% | 50.9% | 50.0% | 45.1% | 44.2% | 40.6% | 40.8% | 37.6% | 31.0% | 25.9% | |
| 13.4% | 16.8% | 23.5% | 24.6% | 23.0% | 23.8% | 26.0% | 19.7% | 17.8% | 11.0% | 5.9% | 0.2% | |
| 2.5% | 3.0% | 4.2% | 6.6% | 3.4% | 2.6% | 3.1% | 2.8% | 3.1% | 2.3% | 4.2% | 1.6% | |
| 37.6% | 28.5% | 25.5% | 21.3% | 14.8% | 10.2% | 5.4% | 5.6% | – | – | – | – | |
| 19.0% | 23.2% | 23.8% | 23.7% | 32.2% | 43.2% | 49.5% | 53.7% | 56.8% | 60.3% | 66.6% | 71.9% | |
| -666.7% | -583.5% | -630.4% | -660.7% | -604.5% | -616.4% | -668.7% | -670.1% | -639.5% | -593.5% | -668.2% | -663.8% | |
| 23.5% | 20.8% | 22.5% | 23.6% | 22.3% | 23.2% | 25.4% | 25.7% | 25.1% | 23.8% | 26.4% | 27.3% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.